cancer clinical trials eligibility

Clinical Trials

Be a part of the cure. Medical research finds ways to help people live longer, improve their quality of life and manage or cure disease. Read More »

 

For more information about clinical trials at The University of Kansas Cancer Center, please email ctnursenav@kumc.edu.

Search by Keyword:

Search Results 1 to 10 of 288
Trial Title Trial Type Study Number (HSC)
MATCH Treatment Subprotocol L: Phase II Study of MLN0128 (TAK-228) in Patients with Tumors with mTOR Mutations Treatment STUDY00002978-L
U2-VEN-207: ULTRA-V: Phase 2II Study to Assess the Efficacy and Safety of Ublituximab in Combination with Umbralisib and Venetoclax (U2-V) in Subjects with Chronic Lymphocytic Leukemia (CLL) Treatment STUDY00143724
Smoking Cessation, Cognitive Control and Reward Processing: An fMRI Pilot study Prevention STUDY00001782
A Phase II Study of Sirolimus in Combination with Metronomic Chemotherapy in Children with Recurrent and/or Refractory Solid and CNS Tumors Treatment CMH - AflacST1502
Prospective Comparative Effectiveness Trial for Malignant Bowel Obstruction. Health Services STUDY00003516
Risk-Stratified Randomized Phase III Testing of Blinatumomab (IND#117467, NSC#765986) in First Relapse of Childhood B-Lymphoblastic Leukemia (B-ALL) Treatment CMH - AALL1331
Long Term Follow-Up of Patients Exposed to Lentiviral-Based CD19 Directed CAR T-Cell Therapy Other CMH - CCTL019A2205B
Phase Ib study of tisagenlecleucel in combination with pembrolizumab in relapsed/refractory (r/r) Diffuse Large Bcell Lymphoma (DLBCL) patients Treatment STUDY00142547
Testing for atypia in random periareolar fine needle aspiration (RPFNA) cytology after 12 months metformin (1, 1-dimethylbiguanide hydrochloride) chemoprevention versus placebo control in premenopausal women Prevention STUDY00004304
Randomized Phase III Trial Evaluating the Role of Weight Loss in Adjuvant Treatment of Overweight and Obese Women with Early Breast Cancer Treatment STUDY00004581